Detail akcie ICON Plc online

Business Summary: ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
Financial Summary: BRIEF: For the three months ended 31 March 2019, ICON PLC revenues increased 9% to $674.9M. Net income increased 13% to $88.3M. Revenues reflect Ireland segment increase of 27% to $298.5M, Rest of World segment increase of 5% to $67.4M. Net income benefited from United States segment income increase of 45% to $17.1M, Rest of World segment income increase of 69% to $8.4M, Ireland segment income increase of 1% to $70.6M.